08:00 , Jan 18, 2016 |  BC Week In Review  |  Company News

Hologic, Metamark Genetics deal

Hologic partnered with Metamark to develop and exclusively co-promote a second-generation prostate cancer diagnostic on Hologic’s Panther platform in to-be-negotiated territories. Hologic also granted Metamark exclusive, worldwide rights to distribute the Progensa PCA3 assay ....
01:36 , Nov 5, 2015 |  BC Extra  |  Company News

Management tracks

Cancer play Jounce Therapeutics Inc. (Cambridge, Mass.) hired Elizabeth Trehu as CMO. She was CMO at Promedior Inc. (Lexington, Mass.). Dermatology company Revance Therapeutics Inc. (NASDAQ:RVNC) said CMO Arthur Bertolino resigned, effective Dec. 31. Co-founder...
00:59 , Oct 15, 2015 |  BC Extra  |  Company News

Management tracks

Cell programming company Fate Therapeutics Inc. (NASDAQ:FATE) said Scott Wolchko will succeed Christian Weyer as president and CEO following Weyer's resignation on Nov. 30. Wolchko was Fate's CFO. Fate also named Daniel Shoemaker CSO and...
00:57 , Sep 15, 2015 |  BC Extra  |  Company News

Management tracks

FDA named new leaders for three country offices in the Office of International Programs. Donald Prater, Mathew Thomas and Edmundo Garcia are now directors of the Europe, India and Latin America offices, respectively. Prater was...
01:38 , Jun 23, 2015 |  BC Extra  |  Company News

Management tracks

Rare disease play Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) named Jayson Dallas chief commercial officer, effective Aug. 3. Dallas was general manager in the U.K. at Roche (SIX:ROG; OTCQX:RHHBY). Hepatic company Intercept Phamaceuticals Inc. (NASDAQ:ICPT) named Juan...
07:00 , Oct 20, 2014 |  BC Week In Review  |  Company News

Metamark Genetics sales and marketing update

Metamark launched the ProMark prostate cancer biopsy test in the U.S. to improve prognosis accuracy. Metamark, which acquired the HealthTronics Laboratories Inc. business of Endo International plc (NASDAQ:ENDP; TSX:ENL, Dublin, Ireland) last year, said at...
08:00 , Feb 3, 2014 |  BC Week In Review  |  Company News

Metamark Genetics management update

Metamark Genetics Inc. , Cambridge, Mass.   Business: Diagnostic   Hired: Jonathan Lieber as SVP and CFO  ...
08:00 , Jan 20, 2014 |  BC Week In Review  |  Company News

Endo, Altaris Capital Partners LLC deal

Investment firm Altaris will acquire Endo's HealthTronics Inc. subsidiary for $85 million up front, plus up to another $45 million based on HealthTronics' future operating performance. The HealthTronics business includes lithotripsy services, prostate treatment services,...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Clinical News

ProMark test: Data

A blinded validation study in formalin-fixed, paraffin-embedded (FFPE) prostate tissue samples showed that ProMark met the primary endpoint of differentiating between indolent and aggressive disease. Metamark could not be reached for details. By year end,...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Company News

Metamark Genetics management update

Metamark Genetics Inc. , Cambridge, Mass.   Business: Diagnostic   Hired: Cornelius Merlini as SVP and chief commercial officer, formerly general manager of HealthTronics Laboratory Solutions Inc., which Metamark acquired  ...